# Neutral Risk Analyst Round 1 - MPL.AX

## Tool Outputs Used
- Aggressive and Conservative risk rounds.
- Market, financial, and sentiment evidence: market:MPL.AX:2026-07-06:001, financial:MPL.AX:2026-07-06:001, social:MPL.AX:2026-07-06:001.

## Risk Argument Quality
- Aggressive evidence quality: medium, because it uses direct financial and news evidence but requires confirmation.
- Conservative evidence quality: medium, because it uses market trend and valuation/timing risk with clear falsification levels.
- Sentiment evidence quality: low; retail-only, noisy, and not decision-grade alone.

## Stronger Risk Side
Stronger risk side: Neutral Risk was stronger because evidence remains mixed and no directional setup is complete. The concrete opportunity is health_insurers metric direction mix: 5 available / 0 gap-labelled; 3 supportive, 1 adverse, 0 mixed, 1 neutral, 0 context-only. supportive examples: premium growth (supportive, financial:MPL.AX:2026-07-06:016); membership (supportive, financial:MPL.AX:2026-07-06:018); adverse examples: claims ratio (adverse, financial:MPL.AX:2026-07-06:017); mixed/neutral examples: operating profit (neutral, financial:MPL.AX:2026-07-06:020). Highlighted metric: premium growth is available / supportive via financial:MPL.AX:2026-07-06:016. This is the strongest concrete opportunity because it is tied to Financial Report Analyst evidence financial:MPL.AX:2026-07-06:016 rather than generic sector language. The concrete risk is Confidence is capped by 0 unavailable sector metric/gap labels, 0 unavailable core financial sections, low-confidence retail sentiment from social:MPL.AX:2026-07-06:001, and medium-confidence extraction depth. Market timing risk is explicit at close 4.97 versus confirmation 5.01 and invalidation/caution 4.92.

## Evidence Gaps
- No options-implied risk, borrow/short-interest feed, or intraday volatility surface was available.

## Memory Update
* Durable facts to retain: This run is a paper-study Codex-session workflow; Python prepared evidence and Codex wrote role interpretation.
* Prior mistake to avoid: Do not let template claims override metric evidence, filing section status, or as-of-date controls.
* Open questions: None for this artifact beyond disclosed evidence gaps.
* Evidence references: market:MPL.AX:2026-07-06:001, financial:MPL.AX:2026-07-06:001, social:MPL.AX:2026-07-06:001
* Staleness / expiry: Evidence is valid only for trade date 2026-07-06; refresh before reuse.
